文献速递心境障碍焦虑、强迫与应激相关障碍会诊联络精神医学

Link-me决策支持工具指导基层精神卫生保健强度的临床疗效:一项实用性分层随机对照试验

Clinical efficacy of a Decision Support Tool (Link-me) to guide intensity of mental health care in primary practice: a pragmatic stratified randomised controlled trial.
PubMed 文献 · Lancet Psychiatry · 2021-02-08

该研究在澳大利亚23家全科诊所纳入1671名有抑郁或焦虑症状的成人,随机接受Link-me预后匹配照护或常规照护加注意对照。

要点

  • Link-me预后匹配照护可小幅降低基层患者6个月心理困扰,重度症状组获益更明显。
  • 轻/微预后组未显示获益,提示该工具主要适用于重度症状患者。

核心结论

  • 基于预后的干预匹配可降低焦虑或抑郁症状患者的心理困扰,重度症状患者获益更明显。
  • 患者实际接受推荐治疗时结局更好,优化并实施Link-me可能有助于减轻常见精神障碍疾病负担。

研究设计与样本

  • 实用性分层随机对照试验,从澳大利亚23家全科诊所招募18-75岁有抑郁或焦虑症状或使用精神卫生药物的成人。
  • 参与者完成Link-me决策支持工具后被分为轻/微、中度、重度三个预后组,轻/微和重度组符合纳入条件。
  • 共1671人被1:1随机分配至干预组(n=834)或常规照护加注意对照组(n=837),参与者未设盲,结局评估设盲。
  • 主要结局为随机化后6个月10项Kessler心理困扰量表评分变化在干预组与对照组之间及预后组内的差异。

主要发现

  • 未记录到严重不良事件。

关键数值与推荐

  • 试验注册号ACTRN12617001333303。

临床怎么用

  • 在基层 practice 中,可使用Link-me对焦虑或抑郁患者进行预后分层,对重度症状者匹配更强化的干预。
  • 轻/微症状患者可能不会从该预后匹配照护中获益,需考虑其他管理策略。
  • 促进患者实际接受推荐治疗可能增强干预效果。

局限性

  • 参与者未设盲,但结局评估设盲,干预提供者仅被告知干预组分配。
  • 轻/微预后组未显示获益,工具在该人群中的应用价值有限。
  • 依从者平均因果效应分析结果需谨慎解读,可能受未依从影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The volume and heterogeneity of mental health problems that primary care patients present with is a substantial challenge for health systems, and both undertreatment and overtreatment are common. We developed Link-me, a patient-completed Decision Support Tool, to predict severity of depression or anxiety, identify priorities, and recommend interventions. In this study, we aimed to examine if Link-me reduces psychological distress among individuals predicted to have minimal/mild or severe symptoms of anxiety or depression. METHODS: In this pragmatic stratified randomised controlled trial, adults aged 18-75 years reporting depressive or anxiety symptoms or use of mental health medication were recruited from 23 general practices in Australia. Participants completed the Decision Support Tool and were classified into three prognostic groups (minimal/mild, moderate, severe), and those in the minimal/mild and severe groups were eligible for inclusion. Participants were individually and randomly assigned (1:1) by a computer-generated allocation sequence to receive either prognosis-matched care (intervention group) or usual care plus attention control (control group). Participants were not blinded but intervention providers were only notified of those allocated to the intervention group. Outcome assessment was blinded. The primary outcome was the difference in the change in scores between the intervention and control group, and within prognostic groups, on the 10-item Kessler Psychological Distress Scale at 6 months post randomisation. The trial was registered on the Australian and New Zealand Clinical Trials Registry, ACTRN12617001333303. OUTCOMES: Between Nov 21, 2017, and Oct 31, 2018, 24 616 patients were invited to complete the eligibility screening survey. 1671 of these patients were included and randomly assigned to either the intervention group (n=834) or the control group (n=837). Prognosis-matched care was associated with greater reductions in psychological distress than usual care plus attention control at 6 months (p=0·03), with a standardised mean difference (SMD) of -0·09 (95% CI -0·17 to -0·01). This reduction was also seen in the severe prognostic group (p=0·003), with a SMD of -0·26 (-0·43 to -0·09), but not in the minimal/mild group (p=0·73), with a SMD of 0·04 (-0·17 to 0·24). In the complier average causal effect analysis in the severe prognostic group, differences were larger among those who received some or all aspects of the intervention (SMD range -0·58 to -1·15). No serious adverse effects were recorded. INTERPRETATION: Prognosis-based matching of interventions reduces psychological distress in patients with anxiety or depressive symptoms, particularly in those with severe symptoms, and is associated with better outcomes when patients access the recommended treatment. Optimisation of the Link-me approach and implementation into routine practice could help reduce the burden of disease associated with common mental health conditions such as anxiety and depression. FUNDING: Australian Government Department of Health.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fletcher S, Spittal MJ, Chondros P, et al. Clinical efficacy of a Decision Support Tool (Link-me) to guide intensity of mental health care in primary practice: a pragmatic stratified randomised controlled trial. Lancet Psychiatry. 2021. PMID: 33571453. doi:10.1016/S2215-0366(20)30517-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。